Insider Trading History of Thomsen Jillian B.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Thomsen Jillian B. since 2008. This trader's CIK number is 1433457. At the time of last reporting, Thomsen Jillian B. was the Chief Financial Officer of Nektar Therapeutics. (stock ticker symbol NKTR). Also see all insider trading activities at Nektar Therapeutics.



Yearly summary of insider trading at Nektar Therapeutics (NKTR) by Thomsen Jillian B.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 NKTR 0 $0 10,267 $30,801 0 $0
2022 NKTR 0 $0 21,305 $98,102 0 $0
2021 NKTR 0 $0 106,785 $1,931,529 75,000 $660,000
2020 NKTR 0 $0 53,604 $1,145,817 37,500 $270,375
2019 NKTR 0 $0 24,377 $898,284 16,119 $172,312
2018 NKTR 0 $0 24,018 $2,071,262 13,881 $148,387
2017 NKTR 0 $0 119,764 $2,343,931 112,500 $1,043,437
2016 NKTR 0 $0 137,397 $2,013,469 133,750 $664,500
2015 NKTR 0 $0 55,000 $736,099 55,000 $365,750
2014 NKTR 0 $0 5,000 $77,800 5,000 $56,900
2011 NKTR 0 $0 0 $0 550 $0
2009 NKTR 0 $0 201 $1,119 550 $0
2008 NKTR 0 $0 203 $887 567 $0


Insider trading of Nektar Therapeutics (NKTR) by Thomsen Jillian B.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-02-16 NKTR Sale 10,267 3.00 30,801
2022-11-16 NKTR Sale 11,095 3.57 39,609
2022-08-16 NKTR Sale 2,006 4.76 9,548
2022-05-16 NKTR Sale 5,841 3.95 23,071
2022-02-16 NKTR Sale 2,363 10.95 25,874
2021-11-16 NKTR Sale 6,741 13.16 88,711
2021-08-16 NKTR Sale 13,339 13.83 184,478
2021-02-16 NKTR Sale 11,705 22.37 261,840
2021-01-28 NKTR Option Ex 75,000 8.80 660,000
2021-01-28 NKTR Sale 75,000 18.62 1,396,500
2020-11-16 NKTR Sale 11,976 16.93 202,753
2020-08-17 NKTR Sale 1,367 19.67 26,888
2020-05-18 NKTR Sale 1,367 22.51 30,771
2020-02-18 NKTR Sale 1,394 22.35 31,155
2020-02-06 NKTR Sale 37,500 22.78 854,250
2020-02-06 NKTR Option Ex 37,500 7.21 270,375
2019-11-18 NKTR Sale 2,713 17.97 48,752
2019-08-16 NKTR Sale 1,809 18.15 32,833
2019-05-16 NKTR Sale 1,928 31.37 60,481
2019-02-19 NKTR Sale 1,808 42.39 76,641
2019-02-04 NKTR Sale 16,119 42.16 679,577
2019-02-04 NKTR Option Ex 16,119 10.69 172,312
2018-11-16 NKTR Sale 4,016 38.25 153,612
2018-05-16 NKTR Sale 3,576 83.39 298,202
2018-04-16 NKTR Option Ex 13,881 10.69 148,387
2018-04-16 NKTR Sale 13,881 101.46 1,408,366
2018-02-16 NKTR Sale 2,545 82.94 211,082
2017-08-16 NKTR Sale 2,648 19.32 51,159
2017-05-16 NKTR Sale 2,651 19.55 51,827
2017-03-20 NKTR Option Ex 112,500 9.28 1,043,437
2017-03-20 NKTR Sale 112,500 19.69 2,215,125
2017-02-16 NKTR Sale 1,965 13.14 25,820
2016-11-16 NKTR Sale 1,986 13.96 27,724
2016-08-16 NKTR Sale 3,971 17.56 69,730
2016-07-11 NKTR Option Ex 100,000 4.65 465,000
2016-07-11 NKTR Sale 100,000 15.09 1,509,000
2016-05-17 NKTR Sale 724 13.58 9,831
2016-05-16 NKTR Option Ex 1,875 .00 0
2016-03-09 NKTR Option Ex 15,000 6.65 99,750
2016-03-09 NKTR Sale 15,000 11.79 176,850
2016-02-16 NKTR Option Ex 1,875 .00 0
2016-02-17 NKTR Sale 716 11.92 8,534
2016-01-19 NKTR Option Ex 15,000 6.65 99,750
2016-01-19 NKTR Sale 15,000 14.12 211,800
2015-12-03 NKTR Sale 15,000 15.87 238,050
2015-12-03 NKTR Option Ex 15,000 6.65 99,750
2015-11-11 NKTR Option Ex 15,000 6.65 99,750
2015-11-11 NKTR Sale 15,000 13.52 202,800
2015-10-06 NKTR Option Ex 15,000 6.65 99,750
2015-10-06 NKTR Sale 15,000 10.99 164,850
2015-09-23 NKTR Option Ex 10,000 6.65 66,500
2015-09-23 NKTR Sale 10,000 13.04 130,399
2014-12-22 NKTR Sale 5,000 15.56 77,800
2014-12-22 NKTR Option Ex 5,000 11.38 56,900
2011-03-07 NKTR Option Ex 550 .00 0
2009-05-12 NKTR Option Ex 550 .00 0
2009-05-12 NKTR Sale 201 5.57 1,119
2008-11-14 NKTR Option Ex 567 .00 0
2008-11-14 NKTR Sale 203 4.37 887

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thomsen Jillian B. (Chief Financial Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.